APO Research
Talk to an analyst

APO RESEARCH · REPORT

Gadolinium-containing Contrast Agent

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Gadolinium-containing Contrast Agent Industry Growth and Trends Forecast to 2032

19 December 202599 pages

Choose your research edition.

Industry ResearchGadolinium-containing Contrast Agent Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Gadolinium-containing Contrast Agent Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Gadolinium-containing Contrast Agent Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gadolinium-containing Contrast Agent Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Gadolinium-containing Contrast Agent Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global Gadolinium-containing Contrast Agent market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Gadolinium-containing Contrast Agent is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Gadolinium-containing Contrast Agent is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Gadolinium-containing Contrast Agent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Gadolinium-containing Contrast Agent include GE, Daiichi Sankyo, BeiLu Pharma, Bayer, YRPG, Liebel-Flarsheim, Lantheus, Guerbet Group and Bracco Imaging, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Gadolinium-containing Contrast Agent market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Gadolinium-containing Contrast Agent market size, estimates, and forecasts are presented in terms of sales volume (kt) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Gadolinium-containing Contrast Agent market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Gadolinium-containing Contrast Agent.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Gadolinium-containing Contrast Agent market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Gadolinium-containing Contrast Agent Market by Company

GE

Daiichi Sankyo

BeiLu Pharma

Bayer

YRPG

Liebel-Flarsheim

Lantheus

Guerbet Group

Bracco Imaging

Gadolinium-containing Contrast Agent Segment by Type

Injection Type

Oral Type

Gadolinium-containing Contrast Agent Segment by Application

Research Medical Center

Hospitals

Clinics

Others

Gadolinium-containing Contrast Agent Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gadolinium-containing Contrast Agent market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gadolinium-containing Contrast Agent and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gadolinium-containing Contrast Agent.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Gadolinium-containing Contrast Agent manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Gadolinium-containing Contrast Agent in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Injection Type Table 2. Major Company of Oral Type Table 3. Global Gadolinium-containing Contrast Agent Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Gadolinium-containing Contrast Agent Sales by Type (2021-2026) & (kt) Table 5. Global Gadolinium-containing Contrast Agent Sales Market Share in Volume by Type (2021-2026) Table 6. Global Gadolinium-containing Contrast Agent Sales by Type (2021-2026) & (US$ Million) Table 7. Global Gadolinium-containing Contrast Agent Sales Market Share in Value by Type (2021-2026) Table 8. Global Gadolinium-containing Contrast Agent Price by Type (2021-2026) & (USD/kg) Table 9. Global Gadolinium-containing Contrast Agent Sales by Type (2027-2032) & (kt) Table 10. Global Gadolinium-containing Contrast Agent Sales Market Share in Volume by Type (2027-2032) Table 11. Global Gadolinium-containing Contrast Agent Sales by Type (2027-2032) & (US$ Million) Table 12. Global Gadolinium-containing Contrast Agent Sales Market Share in Value by Type (2027-2032) Table 13. Global Gadolinium-containing Contrast Agent Price by Type (2027-2032) & (USD/kg) Table 14. North America Gadolinium-containing Contrast Agent Sales by Type (2021-2026) & (kt) Table 15. North America Gadolinium-containing Contrast Agent Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Gadolinium-containing Contrast Agent Sales by Type (2021-2026) & (kt) Table 17. Europe Gadolinium-containing Contrast Agent Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Gadolinium-containing Contrast Agent Sales by Type (2021-2026) & (kt) Table 19. Asia-Pacific Gadolinium-containing Contrast Agent Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Gadolinium-containing Contrast Agent Sales by Type (2021-2026) & (kt) Table 21. Latin America Gadolinium-containing Contrast Agent Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Gadolinium-containing Contrast Agent Sales by Type (2021-2026) & (kt) Table 23. Middle East and Africa Gadolinium-containing Contrast Agent Sales by Type (2021-2026) & (US$ Million) Table 24. Gadolinium-containing Contrast Agent Industry Trends Table 25. Gadolinium-containing Contrast Agent Industry Drivers Table 26. Gadolinium-containing Contrast Agent Industry Opportunities and Challenges Table 27. Gadolinium-containing Contrast Agent Industry Restraints Table 28. Global Gadolinium-containing Contrast Agent Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Gadolinium-containing Contrast Agent Revenue Market Share by Company (2021-2026) Table 30. Global Gadolinium-containing Contrast Agent Sales by Company (2021-2026) & (kt) Table 31. Global Gadolinium-containing Contrast Agent Sales Share by Company (2021-2026) Table 32. Global Gadolinium-containing Contrast Agent Market Price by Company (2021-2026) & (USD/kg) Table 33. Global Gadolinium-containing Contrast Agent Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Gadolinium-containing Contrast Agent Major Company Production Sites and Headquarters Table 35. Global Gadolinium-containing Contrast Agent Company, Product Type & Application Table 36. Global Gadolinium-containing Contrast Agent Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Gadolinium-containing Contrast Agent by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Gadolinium-containing Contrast Agent Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Gadolinium-containing Contrast Agent Sales by Region (2021-2026) & (kt) Table 41. Global Gadolinium-containing Contrast Agent Sales Market Share in Volume by Region (2021-2026) Table 42. Global Gadolinium-containing Contrast Agent Sales by Region (2021-2026) & (US$ Million) Table 43. Global Gadolinium-containing Contrast Agent Sales Market Share in Value by Region (2021-2026) Table 44. Global Gadolinium-containing Contrast Agent Sales (kt), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 45. Global Gadolinium-containing Contrast Agent Sales by Region (2027-2032) & (kt) Table 46. Global Gadolinium-containing Contrast Agent Sales Market Share in Volume by Region (2027-2032) Table 47. Global Gadolinium-containing Contrast Agent Sales by Region (2027-2032) & (US$ Million) Table 48. Global Gadolinium-containing Contrast Agent Sales Market Share in Value by Region (2027-2032) Table 49. Global Gadolinium-containing Contrast Agent Sales (kt), Value (US$ Million), Price (USD/kg) and Gross Margin (2027-2032) Table 50. Global Gadolinium-containing Contrast Agent Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Gadolinium-containing Contrast Agent Sales by Application (2021-2026) & (kt) Table 52. Global Gadolinium-containing Contrast Agent Sales Market Share in Volume by Application (2021-2026) Table 53. Global Gadolinium-containing Contrast Agent Sales by Application (2021-2026) & (US$ Million) Table 54. Global Gadolinium-containing Contrast Agent Sales Market Share in Value by Application (2021-2026) Table 55. Global Gadolinium-containing Contrast Agent Price by Application (2021-2026) & (USD/kg) Table 56. Global Gadolinium-containing Contrast Agent Sales by Application (2027-2032) & (kt) Table 57. Global Gadolinium-containing Contrast Agent Sales Market Share in Volume by Application (2027-2032) Table 58. Global Gadolinium-containing Contrast Agent Sales by Application (2027-2032) & (US$ Million) Table 59. Global Gadolinium-containing Contrast Agent Sales Market Share in Value by Application (2027-2032) Table 60. Global Gadolinium-containing Contrast Agent Price by Application (2027-2032) & (USD/kg) Table 61. North America Gadolinium-containing Contrast Agent Sales by Application (2021-2026) & (kt) Table 62. North America Gadolinium-containing Contrast Agent Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Gadolinium-containing Contrast Agent Sales by Application (2021-2026) & (kt) Table 64. Europe Gadolinium-containing Contrast Agent Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Gadolinium-containing Contrast Agent Sales by Application (2021-2026) & (kt) Table 66. Asia-Pacific Gadolinium-containing Contrast Agent Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Gadolinium-containing Contrast Agent Sales by Application (2021-2026) & (kt) Table 68. Latin America Gadolinium-containing Contrast Agent Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Gadolinium-containing Contrast Agent Sales by Application (2021-2026) & (kt) Table 70. Middle East and Africa Gadolinium-containing Contrast Agent Sales by Application (2021-2026) & (US$ Million) Table 71. GE Company Information Table 72. GE Business Overview Table 73. GE Gadolinium-containing Contrast Agent Sales (kt), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 74. GE Gadolinium-containing Contrast Agent Product Portfolio Table 75. GE Recent Development Table 76. Daiichi Sankyo Company Information Table 77. Daiichi Sankyo Business Overview Table 78. Daiichi Sankyo Gadolinium-containing Contrast Agent Sales (kt), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 79. Daiichi Sankyo Gadolinium-containing Contrast Agent Product Portfolio Table 80. Daiichi Sankyo Recent Development Table 81. BeiLu Pharma Company Information Table 82. BeiLu Pharma Business Overview Table 83. BeiLu Pharma Gadolinium-containing Contrast Agent Sales (kt), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 84. BeiLu Pharma Gadolinium-containing Contrast Agent Product Portfolio Table 85. BeiLu Pharma Recent Development Table 86. Bayer Company Information Table 87. Bayer Business Overview Table 88. Bayer Gadolinium-containing Contrast Agent Sales (kt), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 89. Bayer Gadolinium-containing Contrast Agent Product Portfolio Table 90. Bayer Recent Development Table 91. YRPG Company Information Table 92. YRPG Business Overview Table 93. YRPG Gadolinium-containing Contrast Agent Sales (kt), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 94. YRPG Gadolinium-containing Contrast Agent Product Portfolio Table 95. YRPG Recent Development Table 96. Liebel-Flarsheim Company Information Table 97. Liebel-Flarsheim Business Overview Table 98. Liebel-Flarsheim Gadolinium-containing Contrast Agent Sales (kt), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 99. Liebel-Flarsheim Gadolinium-containing Contrast Agent Product Portfolio Table 100. Liebel-Flarsheim Recent Development Table 101. Lantheus Company Information Table 102. Lantheus Business Overview Table 103. Lantheus Gadolinium-containing Contrast Agent Sales (kt), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 104. Lantheus Gadolinium-containing Contrast Agent Product Portfolio Table 105. Lantheus Recent Development Table 106. Guerbet Group Company Information Table 107. Guerbet Group Business Overview Table 108. Guerbet Group Gadolinium-containing Contrast Agent Sales (kt), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 109. Guerbet Group Gadolinium-containing Contrast Agent Product Portfolio Table 110. Guerbet Group Recent Development Table 111. Bracco Imaging Company Information Table 112. Bracco Imaging Business Overview Table 113. Bracco Imaging Gadolinium-containing Contrast Agent Sales (kt), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 114. Bracco Imaging Gadolinium-containing Contrast Agent Product Portfolio Table 115. Bracco Imaging Recent Development Table 116. North America Gadolinium-containing Contrast Agent Market Size Growth Rate (CAGR) by Country (kt): 2021 VS 2025 VS 2032 Table 117. North America Gadolinium-containing Contrast Agent Sales by Country (2021-2026) & (kt) Table 118. North America Gadolinium-containing Contrast Agent Sales Market Share by Country (2021-2026) Table 119. North America Gadolinium-containing Contrast Agent Sales Forecast by Country (2027-2032) & (kt) Table 120. North America Gadolinium-containing Contrast Agent Sales Market Share Forecast by Country (2027-2032) Table 121. North America Gadolinium-containing Contrast Agent Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. North America Gadolinium-containing Contrast Agent Market Size by Country (2021-2026) & (US$ Million) Table 123. North America Gadolinium-containing Contrast Agent Market Share by Country (2021-2026) Table 124. North America Gadolinium-containing Contrast Agent Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. North America Gadolinium-containing Contrast Agent Market Share Forecast by Country (2027-2032) Table 126. Europe Gadolinium-containing Contrast Agent Market Size Growth Rate (CAGR) by Country (kt): 2021 VS 2025 VS 2032 Table 127. Europe Gadolinium-containing Contrast Agent Sales by Country (2021-2026) & (kt) Table 128. Europe Gadolinium-containing Contrast Agent Sales Market Share by Country (2021-2026) Table 129. Europe Gadolinium-containing Contrast Agent Sales Forecast by Country (2027-2032) & (kt) Table 130. Europe Gadolinium-containing Contrast Agent Sales Market Share Forecast by Country (2027-2032) Table 131. Europe Gadolinium-containing Contrast Agent Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Europe Gadolinium-containing Contrast Agent Market Size by Country (2021-2026) & (US$ Million) Table 133. Europe Gadolinium-containing Contrast Agent Market Share by Country (2021-2026) Table 134. Europe Gadolinium-containing Contrast Agent Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Europe Gadolinium-containing Contrast Agent Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific Gadolinium-containing Contrast Agent Market Size Growth Rate (CAGR) by Country (kt): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific Gadolinium-containing Contrast Agent Sales by Country (2021-2026) & (kt) Table 138. Asia-Pacific Gadolinium-containing Contrast Agent Sales Market Share by Country (2021-2026) Table 139. Asia-Pacific Gadolinium-containing Contrast Agent Sales Forecast by Country (2027-2032) & (kt) Table 140. Asia-Pacific Gadolinium-containing Contrast Agent Sales Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Gadolinium-containing Contrast Agent Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Gadolinium-containing Contrast Agent Market Size by Country (2021-2026) & (US$ Million) Table 143. Asia-Pacific Gadolinium-containing Contrast Agent Market Share by Country (2021-2026) Table 144. Asia-Pacific Gadolinium-containing Contrast Agent Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Asia-Pacific Gadolinium-containing Contrast Agent Market Share Forecast by Country (2027-2032) Table 146. Latin America Gadolinium-containing Contrast Agent Market Size Growth Rate (CAGR) by Country (kt): 2021 VS 2025 VS 2032 Table 147. Latin America Gadolinium-containing Contrast Agent Sales by Country (2021-2026) & (kt) Table 148. Latin America Gadolinium-containing Contrast Agent Sales Market Share by Country (2021-2026) Table 149. Latin America Gadolinium-containing Contrast Agent Sales Forecast by Country (2027-2032) & (kt) Table 150. Latin America Gadolinium-containing Contrast Agent Sales Market Share Forecast by Country (2027-2032) Table 151. Latin America Gadolinium-containing Contrast Agent Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Latin America Gadolinium-containing Contrast Agent Market Size by Country (2021-2026) & (US$ Million) Table 153. Latin America Gadolinium-containing Contrast Agent Market Share by Country (2021-2026) Table 154. Latin America Gadolinium-containing Contrast Agent Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Latin America Gadolinium-containing Contrast Agent Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa Gadolinium-containing Contrast Agent Market Size Growth Rate (CAGR) by Country (kt): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa Gadolinium-containing Contrast Agent Sales by Country (2021-2026) & (kt) Table 158. Middle East and Africa Gadolinium-containing Contrast Agent Sales Market Share by Country (2021-2026) Table 159. Middle East and Africa Gadolinium-containing Contrast Agent Sales Forecast by Country (2027-2032) & (kt) Table 160. Middle East and Africa Gadolinium-containing Contrast Agent Sales Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Gadolinium-containing Contrast Agent Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Gadolinium-containing Contrast Agent Market Size by Country (2021-2026) & (US$ Million) Table 163. Middle East and Africa Gadolinium-containing Contrast Agent Market Share by Country (2021-2026) Table 164. Middle East and Africa Gadolinium-containing Contrast Agent Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Middle East and Africa Gadolinium-containing Contrast Agent Market Share Forecast by Country (2027-2032) Table 166. Key Raw Materials Table 167. Raw Materials Key Suppliers Table 168. Gadolinium-containing Contrast Agent Distributors List Table 169. Gadolinium-containing Contrast Agent Customers List Table 170. Research Programs/Design for This Report Table 171. Authors List of This Report Table 172. Secondary Sources Table 173. Primary Sources List of Figures Figure 1. Gadolinium-containing Contrast Agent Image Figure 2. Global Gadolinium-containing Contrast Agent Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Gadolinium-containing Contrast Agent Market Size (2021-2032) & (US$ Million) Figure 4. Global Gadolinium-containing Contrast Agent Sales (2021-2032) & (kt) Figure 5. Injection Type Image Figure 6. Global Injection Type Sales YoY Growth (2021-2032) & (kt) Figure 7. Oral Type Image Figure 8. Global Oral Type Sales YoY Growth (2021-2032) & (kt) Figure 9. Global Gadolinium-containing Contrast Agent Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Gadolinium-containing Contrast Agent Market Share by Type 2025 VS 2032 Figure 11. North America Gadolinium-containing Contrast Agent Sales Market Share in Volume by Type in 2025 Figure 12. North America Gadolinium-containing Contrast Agent Sales Market Share in Value by Type in 2025 Figure 13. Europe Gadolinium-containing Contrast Agent Sales Market Share in Volume by Type in 2025 Figure 14. Europe Gadolinium-containing Contrast Agent Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Gadolinium-containing Contrast Agent Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Gadolinium-containing Contrast Agent Sales Market Share in Value by Type in 2025 Figure 17. Latin America Gadolinium-containing Contrast Agent Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Gadolinium-containing Contrast Agent Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Gadolinium-containing Contrast Agent Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Gadolinium-containing Contrast Agent Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Gadolinium-containing Contrast Agent Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Research Medical Center Image Figure 24. Global Research Medical Center Sales YoY Growth (2021-2032) & (kt) Figure 25. Hospitals Image Figure 26. Global Hospitals Sales YoY Growth (2021-2032) & (kt) Figure 27. Clinics Image Figure 28. Global Clinics Sales YoY Growth (2021-2032) & (kt) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (kt) Figure 31. Global Gadolinium-containing Contrast Agent Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Gadolinium-containing Contrast Agent Market Share by Application 2025 VS 2032 Figure 33. North America Gadolinium-containing Contrast Agent Sales Market Share in Volume by Application in 2025 Figure 34. North America Gadolinium-containing Contrast Agent Sales Market Share in Value by Application in 2025 Figure 35. Europe Gadolinium-containing Contrast Agent Sales Market Share in Volume by Application in 2025 Figure 36. Europe Gadolinium-containing Contrast Agent Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Gadolinium-containing Contrast Agent Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Gadolinium-containing Contrast Agent Sales Market Share in Value by Application in 2025 Figure 39. Latin America Gadolinium-containing Contrast Agent Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Gadolinium-containing Contrast Agent Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Gadolinium-containing Contrast Agent Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Gadolinium-containing Contrast Agent Sales Market Share in Value by Application in 2025 Figure 43. North America Gadolinium-containing Contrast Agent Sales by Country: 2021 VS 2025 VS 2032 (kt) Figure 44. North America Gadolinium-containing Contrast Agent Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Gadolinium-containing Contrast Agent Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Gadolinium-containing Contrast Agent Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Gadolinium-containing Contrast Agent Sales by Country: 2021 VS 2025 VS 2032 (kt) Figure 48. Europe Gadolinium-containing Contrast Agent Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Gadolinium-containing Contrast Agent Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Gadolinium-containing Contrast Agent Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Gadolinium-containing Contrast Agent Sales by Country: 2021 VS 2025 VS 2032 (kt) Figure 52. Asia-Pacific Gadolinium-containing Contrast Agent Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Gadolinium-containing Contrast Agent Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Gadolinium-containing Contrast Agent Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Gadolinium-containing Contrast Agent Sales by Country: 2021 VS 2025 VS 2032 (kt) Figure 56. Latin America Gadolinium-containing Contrast Agent Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Gadolinium-containing Contrast Agent Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Gadolinium-containing Contrast Agent Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Gadolinium-containing Contrast Agent Sales by Country: 2021 VS 2025 VS 2032 (kt) Figure 60. Middle East and Africa Gadolinium-containing Contrast Agent Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Gadolinium-containing Contrast Agent Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Gadolinium-containing Contrast Agent Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Gadolinium-containing Contrast Agent Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Gadolinium-containing Contrast Agent Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Injection Type
  • Oral Type
Applications
  • Research Medical Center
  • Hospitals
  • Clinics
  • Others
Companies covered
  • GE
  • Daiichi Sankyo
  • BeiLu Pharma
  • Bayer
  • YRPG
  • Liebel-Flarsheim
  • Lantheus
  • Guerbet Group
  • Bracco Imaging

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Gadolinium-containing Contrast Agent Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Gadolinium-containing Contrast Agent Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Gadolinium-containing Contrast Agent Market by Type
  6. 1.3.1 Injection Type
  7. 1.3.2 Oral Type
  8. 1.4 Global Gadolinium-containing Contrast Agent Market Size by Type
  9. 1.4.1 Global Gadolinium-containing Contrast Agent Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Gadolinium-containing Contrast Agent Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Gadolinium-containing Contrast Agent Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Gadolinium-containing Contrast Agent Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Gadolinium-containing Contrast Agent Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Gadolinium-containing Contrast Agent Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Gadolinium-containing Contrast Agent Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Gadolinium-containing Contrast Agent Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Gadolinium-containing Contrast Agent Industry Trends
  2. 2.2 Gadolinium-containing Contrast Agent Industry Drivers
  3. 2.3 Gadolinium-containing Contrast Agent Industry Opportunities and Challenges
  4. 2.4 Gadolinium-containing Contrast Agent Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Gadolinium-containing Contrast Agent Revenue (2021-2026)
  2. 3.2 Global Top Players by Gadolinium-containing Contrast Agent Sales (2021-2026)
  3. 3.3 Global Top Players by Gadolinium-containing Contrast Agent Price (2021-2026)
  4. 3.4 Global Gadolinium-containing Contrast Agent Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Gadolinium-containing Contrast Agent Major Company Production Sites & Headquarters
  6. 3.6 Global Gadolinium-containing Contrast Agent Company, Product Type & Application
  7. 3.7 Global Gadolinium-containing Contrast Agent Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Gadolinium-containing Contrast Agent Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Gadolinium-containing Contrast Agent Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Gadolinium-containing Contrast Agent Tier 1, Tier 2, and Tier 3
4 Gadolinium-containing Contrast Agent Regional Status and Outlook
  1. 4.1 Global Gadolinium-containing Contrast Agent Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Gadolinium-containing Contrast Agent Historic Market Size by Region
  3. 4.2.1 Global Gadolinium-containing Contrast Agent Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Gadolinium-containing Contrast Agent Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Gadolinium-containing Contrast Agent Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Gadolinium-containing Contrast Agent Forecasted Market Size by Region
  7. 4.3.1 Global Gadolinium-containing Contrast Agent Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Gadolinium-containing Contrast Agent Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Gadolinium-containing Contrast Agent Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Gadolinium-containing Contrast Agent by Application
  1. 5.1 Gadolinium-containing Contrast Agent Market by Application
  2. 5.1.1 Research Medical Center
  3. 5.1.2 Hospitals
  4. 5.1.3 Clinics
  5. 5.1.4 Others
  6. 5.2 Global Gadolinium-containing Contrast Agent Market Size by Application
  7. 5.2.1 Global Gadolinium-containing Contrast Agent Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Gadolinium-containing Contrast Agent Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Gadolinium-containing Contrast Agent Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Gadolinium-containing Contrast Agent Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Gadolinium-containing Contrast Agent Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Gadolinium-containing Contrast Agent Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Gadolinium-containing Contrast Agent Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Gadolinium-containing Contrast Agent Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 GE
  2. 6.1.1 GE Company Information
  3. 6.1.2 GE Business Overview
  4. 6.1.3 GE Gadolinium-containing Contrast Agent Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 GE Gadolinium-containing Contrast Agent Product Portfolio
  6. 6.1.5 GE Recent Developments
  7. 6.2 Daiichi Sankyo
  8. 6.2.1 Daiichi Sankyo Company Information
  9. 6.2.2 Daiichi Sankyo Business Overview
  10. 6.2.3 Daiichi Sankyo Gadolinium-containing Contrast Agent Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Daiichi Sankyo Gadolinium-containing Contrast Agent Product Portfolio
  12. 6.2.5 Daiichi Sankyo Recent Developments
  13. 6.3 BeiLu Pharma
  14. 6.3.1 BeiLu Pharma Company Information
  15. 6.3.2 BeiLu Pharma Business Overview
  16. 6.3.3 BeiLu Pharma Gadolinium-containing Contrast Agent Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 BeiLu Pharma Gadolinium-containing Contrast Agent Product Portfolio
  18. 6.3.5 BeiLu Pharma Recent Developments
  19. 6.4 Bayer
  20. 6.4.1 Bayer Company Information
  21. 6.4.2 Bayer Business Overview
  22. 6.4.3 Bayer Gadolinium-containing Contrast Agent Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Bayer Gadolinium-containing Contrast Agent Product Portfolio
  24. 6.4.5 Bayer Recent Developments
  25. 6.5 YRPG
  26. 6.5.1 YRPG Company Information
  27. 6.5.2 YRPG Business Overview
  28. 6.5.3 YRPG Gadolinium-containing Contrast Agent Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 YRPG Gadolinium-containing Contrast Agent Product Portfolio
  30. 6.5.5 YRPG Recent Developments
  31. 6.6 Liebel-Flarsheim
  32. 6.6.1 Liebel-Flarsheim Company Information
  33. 6.6.2 Liebel-Flarsheim Business Overview
  34. 6.6.3 Liebel-Flarsheim Gadolinium-containing Contrast Agent Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Liebel-Flarsheim Gadolinium-containing Contrast Agent Product Portfolio
  36. 6.6.5 Liebel-Flarsheim Recent Developments
  37. 6.7 Lantheus
  38. 6.7.1 Lantheus Company Information
  39. 6.7.2 Lantheus Business Overview
  40. 6.7.3 Lantheus Gadolinium-containing Contrast Agent Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Lantheus Gadolinium-containing Contrast Agent Product Portfolio
  42. 6.7.5 Lantheus Recent Developments
  43. 6.8 Guerbet Group
  44. 6.8.1 Guerbet Group Company Information
  45. 6.8.2 Guerbet Group Business Overview
  46. 6.8.3 Guerbet Group Gadolinium-containing Contrast Agent Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Guerbet Group Gadolinium-containing Contrast Agent Product Portfolio
  48. 6.8.5 Guerbet Group Recent Developments
  49. 6.9 Bracco Imaging
  50. 6.9.1 Bracco Imaging Company Information
  51. 6.9.2 Bracco Imaging Business Overview
  52. 6.9.3 Bracco Imaging Gadolinium-containing Contrast Agent Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Bracco Imaging Gadolinium-containing Contrast Agent Product Portfolio
  54. 6.9.5 Bracco Imaging Recent Developments
7 North America by Country
  1. 7.1 North America Gadolinium-containing Contrast Agent Sales by Country
  2. 7.1.1 North America Gadolinium-containing Contrast Agent Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Gadolinium-containing Contrast Agent Sales by Country (2021-2026)
  4. 7.1.3 North America Gadolinium-containing Contrast Agent Sales Forecast by Country (2027-2032)
  5. 7.2 North America Gadolinium-containing Contrast Agent Market Size by Country
  6. 7.2.1 North America Gadolinium-containing Contrast Agent Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Gadolinium-containing Contrast Agent Market Size by Country (2021-2026)
  8. 7.2.3 North America Gadolinium-containing Contrast Agent Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Gadolinium-containing Contrast Agent Sales by Country
  2. 8.1.1 Europe Gadolinium-containing Contrast Agent Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Gadolinium-containing Contrast Agent Sales by Country (2021-2026)
  4. 8.1.3 Europe Gadolinium-containing Contrast Agent Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Gadolinium-containing Contrast Agent Market Size by Country
  6. 8.2.1 Europe Gadolinium-containing Contrast Agent Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Gadolinium-containing Contrast Agent Market Size by Country (2021-2026)
  8. 8.2.3 Europe Gadolinium-containing Contrast Agent Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Gadolinium-containing Contrast Agent Sales by Country
  2. 9.1.1 Asia-Pacific Gadolinium-containing Contrast Agent Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Gadolinium-containing Contrast Agent Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Gadolinium-containing Contrast Agent Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Gadolinium-containing Contrast Agent Market Size by Country
  6. 9.2.1 Asia-Pacific Gadolinium-containing Contrast Agent Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Gadolinium-containing Contrast Agent Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Gadolinium-containing Contrast Agent Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Gadolinium-containing Contrast Agent Sales by Country
  2. 10.1.1 South America Gadolinium-containing Contrast Agent Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Gadolinium-containing Contrast Agent Sales by Country (2021-2026)
  4. 10.1.3 South America Gadolinium-containing Contrast Agent Sales Forecast by Country (2027-2032)
  5. 10.2 South America Gadolinium-containing Contrast Agent Market Size by Country
  6. 10.2.1 South America Gadolinium-containing Contrast Agent Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Gadolinium-containing Contrast Agent Market Size by Country (2021-2026)
  8. 10.2.3 South America Gadolinium-containing Contrast Agent Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Gadolinium-containing Contrast Agent Sales by Country
  2. 11.1.1 Middle East and Africa Gadolinium-containing Contrast Agent Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Gadolinium-containing Contrast Agent Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Gadolinium-containing Contrast Agent Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Gadolinium-containing Contrast Agent Market Size by Country
  6. 11.2.1 Middle East and Africa Gadolinium-containing Contrast Agent Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Gadolinium-containing Contrast Agent Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Gadolinium-containing Contrast Agent Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Gadolinium-containing Contrast Agent Value Chain Analysis
  2. 12.1.1 Gadolinium-containing Contrast Agent Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Gadolinium-containing Contrast Agent Production Mode & Process
  7. 12.2 Gadolinium-containing Contrast Agent Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Gadolinium-containing Contrast Agent Distributors
  10. 12.2.3 Gadolinium-containing Contrast Agent Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst